−25.15 M USD
0.00 USD
4.39 M
About Check-Cap Ltd.
Sector
Industry
CEO
David Lontini
Website
Headquarters
Isfiya
Founded
2005
ISIN
IL0011336851
FIGI
BBG0089RJVS4
Check-Cap Ltd. is a clinical stage medical diagnostics company, which engages in the development of ingestible imaging capsule systems for colorectal cancer screening. Its patented technology, C-Scan, is a patient-friendly preparation-free test designed to detect polyps before they may transform into cancer. The company was founded by Yoav Kimchy in 2005 and is headquartered in Isfiya, Israel.
Related stocks
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on BOATS exchange Check-Cap Ltd. stocks are traded under the ticker CHEK.
CHEK reached its all-time high on Aug 29, 2022 with the price of 7.8780 USD, and its all-time low was 0.7000 USD and was reached on Aug 14, 2025. View more price dynamics on CHEK chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track Check-Cap Ltd. financials in yearly and quarterly reports right on TradingView.
No, CHEK doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CHEK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Check-Cap Ltd. stock right from TradingView charts — choose your broker and connect to your account.